STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Communication Services Entertainment
investing

Rumble Shares Surge as Dr Disrespect Joins Platform

byLuca Blaumann
November 25, 2024
in Entertainment, Mid-Cap
Reading Time: 2 mins read
Share on TwitterShare on LinkedIn

Gaming star’s partnership sparks excitement, adding momentum to the streaming company

Rumble (RUM), the conservative-leaning video-streaming platform, saw its shares rise as much as 17% on Monday following the announcement that prominent online personality Guy Beahm, widely known as Dr Disrespect, will lead Rumble Gaming. This move is seen as a strategic effort to expand Rumble’s presence in the competitive gaming and streaming space.

Dr Disrespect will provide both free and premium content on Rumble, with his inaugural show set to debut on December 2, according to the company’s press release. As part of his agreement with Rumble, Beahm will receive equity tied to specific performance milestones, signaling a long-term commitment to the platform.

“Dr Disrespect will give a much-needed injection into our gaming category,” stated Rumble Chairman and CEO Chris Pavlovski. The announcement was well-received by investors, adding over $220 million to Rumble’s market capitalization in a single day.

A Controversial Figure

Beahm’s partnership with Rumble comes after his YouTube channel was demonetized earlier this year. Reports allege that his 2020 ban from Amazon’s Twitch stemmed from inappropriate interactions with a minor, including sexually explicit messages and inquiries about her plans during the TwitchCon convention. While Beahm has denied the allegations, the controversy has shadowed his otherwise celebrated career.

In September, Beahm revealed that he had applied to re-monetize his YouTube channel, but his request was denied. He plans to reapply in the coming months. The move to Rumble offers him a fresh start and a platform that aligns with his audience’s values and his brand’s appeal.

Rumble’s Growth and Challenges

Rumble has been on an upward trajectory, with shares gaining nearly 60% this year. The company, which went public through a special purpose acquisition company (SPAC) merger in 2022, counts notable backers like Peter Thiel and Vice President-elect JD Vance. However, the stock remains below its 2022 highs, reflecting ongoing challenges in scaling its revenue.

In mid-November, Rumble reported earnings that missed analyst expectations, causing a temporary decline in its stock price. The partnership with Dr Disrespect could help reinvigorate investor confidence by attracting a broader audience to its platform.

Looking Ahead

As Rumble continues to position itself as a competitor to mainstream streaming platforms, Dr Disrespect’s addition could be a game-changer for its gaming segment. Investors and audiences will be watching closely to see if this high-profile partnership delivers on its promise of growth and engagement.

You might like this article:Bitcoin Stalls Below $100K: What’s Next for the Leading Cryptocurrency?

Tags: GrowthMoversNewsStock Market
Previous Post

Bitcoin Stalls Below $100K: What’s Next for the Leading Cryptocurrency?

Next Post

Qualcomm’s Interest in Acquiring Intel Cools as Challenges Mount

Related Posts

Orion Group Holdings Delivers Strong Q3 Results and Raises 2025 Guidance

byLuca Blaumann
October 28, 2025
0

Robust operational performance, $225 million in revenue, and expanded bonding capacity position Orion for sustained growth Orion Group Holdings (ORN),...

investing

Datavault AI and Wellgistics Partner to Revolutionize Prescription Tracking with Blockchain Technology

byLiliana Vida
October 24, 2025
0

Collaboration aims to enhance transparency, efficiency, and patient safety through smart contract integration Datavault AI (DVLT), a leader in AI-powered...

investing

Beyond Meat’s (BYND) Rocky Road: Near-Term Opportunity or Caution Ahead?

byLuca Blaumann
October 22, 2025
0

From deep financial stress to meme-stock mania — what comes next for the plant-based company Beyond Meat (BYND) is again...

Next Post
semiconductor

Qualcomm’s Interest in Acquiring Intel Cools as Challenges Mount

Latest News

Amazon Soars 9% After Beating Q3 Estimates on Strong AWS Growth

Intensity Therapeutics Publishes Promising Phase 1/2 Results for Novel Cancer Drug INT230-6

Core Scientific Scraps $9 Billion Sale to CoreWeave After Shareholder Rejection

Alphabet Tops $100 Billion Quarter as AI Cloud Deals Power Record Growth

Microsoft Reports Strong Q3 Results Driven by Cloud and AI Momentum

Based on Your Interest

investing
Mega-Cap

Meta Beats on Revenue, Misses EPS as One-Time Tax Charge Weighs on Q3

October 29, 2025
scientist
Biotechnology

Purple Biotech Reaches Key Manufacturing Milestone for Groundbreaking Tri-Specific Antibody IM1240

October 29, 2025
Building Materials

Orion Group Holdings Delivers Strong Q3 Results and Raises 2025 Guidance

October 28, 2025

Recommended

Artificial Intelligence

Nvidia Partners with U.S. Department of Energy to Build Seven AI Supercomputers

October 28, 2025
Artificial Intelligence

Qualcomm Enters the AI Data Center Battle with Powerful New AI200 and AI250 Chips

October 27, 2025
Biotechnology

Co-Diagnostics Expands Global Reach with New Saudi Joint Venture

October 27, 2025
Artificial Intelligence

Datavault AI and Wellgistics Partner to Revolutionize Prescription Tracking with Blockchain Technology

October 24, 2025
Large-Cap

AMD Shares Surge as IBM Taps Its Chips for Quantum Computing Breakthrough

October 24, 2025
Stoxpo

Follow us on social media:

Highlights

  • Amazon Soars 9% After Beating Q3 Estimates on Strong AWS Growth
  • Intensity Therapeutics Publishes Promising Phase 1/2 Results for Novel Cancer Drug INT230-6
  • Core Scientific Scraps $9 Billion Sale to CoreWeave After Shareholder Rejection
  • Alphabet Tops $100 Billion Quarter as AI Cloud Deals Power Record Growth
  • Microsoft Reports Strong Q3 Results Driven by Cloud and AI Momentum

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

amazon

Amazon Soars 9% After Beating Q3 Estimates on Strong AWS Growth

October 30, 2025
chemistry

Intensity Therapeutics Publishes Promising Phase 1/2 Results for Novel Cancer Drug INT230-6

October 30, 2025

Core Scientific Scraps $9 Billion Sale to CoreWeave After Shareholder Rejection

October 30, 2025
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.